Key Takeaways from BioAmber's IPO Filing

Another day, another biochemical S-1. BioAmber, a biobased succinic acid producer based in Minneapolis, announced yesterday that is has filed for an initial public offering of up to $150 million.  The move isn’t too surprising, given the pace in which the company has racked up partnerships and the general momentum late-stage biochemical start-ups have built in 2011 (For more on the latter, see recent CW cover story Green Chemicals: Coming to a Supply Chain Near You). The company has partnered with Mitsui & Co. to build up to three commercial-scale...

This information is only available to Chemical Week subscribers.

Forgot your user ID or password?
Click here to have it sent to you.

Email Address First Name Last Name

Not an IHS Chemical Week 24/7 member yet? Here's why you should be: Searchable online archive access of the last 2 years of Chemical Week. Print or digital magazine subscription Price and market change alerts Economic data and statistics Buyers' Guides Webcasts | whitepapers